Positive developments from an Australian investment lifted a Canadian cannabis stock Friday. Here’s some small stocks making big moves on Friday, October 5, 2018 (as of 4 pm EST):
LGC Capital Ltd. (TSXV:LG), a Canadian cannabis stock, climbed 11% to $0.20 on Friday after announcing that Australian medical cannabis company Little Green Pharma, in which LGC has a 14.21% interest, has successfully completed harvest of its second commercial medical cannabis crop from its facility in Western Australia. Little Green Pharma products have also been accepted into major statewide clinical trials for advanced cancer, and the company has begun negotiations for exports to Germany.
As well, shares of Centamin plc (TSX:CEE) fell 12% to $1.62 as the gold miner said preliminary production results for the third quarter from its Sukari Gold Mine in Egypt totaled 117,720 ounces, a 27% improvement on the second quarter. The Company added, though, that operational improvements have taken longer than planned to materialize.
Aritzia Inc. (TSX:ATZ), meanwhile, reported 11.5% comparable sales growth for its second quarter of fiscal 2019, along with a 76.3% increase in adjusted net income for the period. Aritzia stock moved up 14% to $18.39 following the announcement.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
LGC Capital Ltd. (TSXV:LG), a Canadian cannabis stock, climbed 11% to $0.20 on Friday after announcing that Australian medical cannabis company Little Green Pharma, in which LGC has a 14.21% interest, has successfully completed harvest of its second commercial medical cannabis crop from its facility in Western Australia. Little Green Pharma products have also been accepted into major statewide clinical trials for advanced cancer, and the company has begun negotiations for exports to Germany.
